Representative before the EPO

Technology company logo thumb
no operation time available
1 office
Technology Company

We have observed 2 EP applications Henrik Skødt has served for within the last five+ years. (We consider all applications which have an EP A1 or A2 publication dated after June 21, 2013). Please note, that we only count EP applications, in which the name of the patent attorney is explicitly mentioned as representative. These EP applications are:

EP14150805

Aqueous pharmaceutical compositions containing borate-polyol complexes

IPC classification:
A61K 47/32, A61K 47/18, A61K 47/10, A61K 47/02, A61K 31/542, A61K 31/52, A61K 31/335, A61K 9/00
Applicant:
Novartis AG
Applicant:
Alcon Research, Ltd
Agent:
Henrik Skødt, Novartis Pharma AG
Agent:
Stephan Teipel, Lederer Keller Patentanwälte Partnerschaft mbB
Status:
PATENT GRANTED
EP12705608

mTOR/JAK INHIBITOR COMBINATION THERAPY

IPC classification:
A61P 35/00, A61K 31/519, A61K 31/436
Applicant:
Novartis Pharma AG
Agent:
Multiple attorneys, Novartis Pharma AG
Agent:
Zöe Clyde-Watson, D Young & Co LLP
Status:
The patent has been granted

Please Sign in to use this feature